SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mopgcw1/7/2006 6:11:55 AM
   of 3044
 
waiting on:

January 2006: Competitor Revlimid
(CELG) approval

1H06: Final data from phase II single
agent trial of Velcade in Mantle Cell
Lymphoma

1H06: Final data from SWOG phase II
trial of Velcade, gemcitabine and
carboplatin in front-line NSCLC

1H06: MLN1202 phase IIa data in
atherosclerosis

June 2006: Data at ASCO meeting

2H06: MLN1202 phase IIa data in RA
and MS

dont know why i still hold it...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News